The one-year survival rate of lung transplantation is 8-9%, and the five-year survival rate is about 4-5%. Tissue matching, donor lung quality and recipient condition are the main factors affecting long-term survival.

broadly speaking, terminal lung diseases are indications for lung transplantation. At present, the most common clinical diseases are emphysema, pulmonary fibrosis, pulmonary cystic fibrosis, α1 antitrypsin deficiency, bronchiectasis and some occupational diseases. Lung cancer is not the indication of lung transplantation in principle, and some tumors with low lung malignancy and alveolar cell carcinoma involving only one lung may occasionally become the indication of lung transplantation.

The total cost of lung transplantation during hospitalization is 3,-4, yuan, and anti-rejection drugs need to be taken for a long time after operation. According to different kinds of drugs, the annual drug cost is 3,-4, yuan.